Bottlenecks of digital transformation in China's biopharmaceutical industry and corresponding suggestions
As an emerging emerging industry in China,the biopharmaceutical industry is facing difficulties both internally and externally.Digital transformation has become a necessary path for overcoming adversities.However,the digital transformation of the biopharmaceutical industry is currently constrained by four major bottlenecks:insufficient data foundation,relatively lagging policy regulation,lack of targeted evaluation systems,and shortage of compound talents.The progress of transformation is relatively backward.It is recommended to accelerate the digital transformation of the biopharmaceutical industry by unifying data standards,establishing public data resource systems,innovating regulatory models,constructing transformation evaluation systems,and cultivating talent teams.
digital transformationbiopharmaceutical industrypharmacybottlenecksuggestion
国家科技期刊平台
NSTL
万方数据
